ライフサイエンス研究メディア

バイオマーケットjpはバイオ・ライフサイエンス研究に役立つ情報を発信するWebメディアです

Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report


Posted: 2021-10-08 19:00:00
J Infect Chemother . 2021 Oct 2;S1341-321X(21)00263-4. doi: 10.1016/j.jiac.2021.09.014. Online ahead of print. Kyohei Miyamoto 1 , Yusuke Koizumi 2 , Shinobu Tamura 3 , Tsuyoshi Nakashima 4 , Kaori Kobai 5 , Rikako Tanaka 4 , Mami Shibata 4 , Nozomu Shima 4 , Shigeki Nemoto 4 , Nobu Fukumoto 4 , Seiya Kato 4 Affiliations Expand Affiliations 1 Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. Electronic address: gomadofu@wakayama-med.ac.jp. 2 Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. 3 Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Hematology/Oncology, Wakayama Medical University, Wakayama City, Wakayama, Japan. 4 Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan. 5 Department of Anesthesiology, Wakayama Medical University, Wakayama City, Wakayama, Japan. Item in Clipboard Kyohei Miyamoto et al. J Infect Chemother. 2021. Show details Display options Display options Format J Infect Chemother . 2021 Oct 2;S1341-321X(21)00263-4. doi: 10.1016/j.jiac.2021.09.014. Online ahead of print. Authors Kyohei Miyamoto 1 , Yusuke Koizumi 2 , Shinobu Tamura 3 , Tsuyoshi Nakashima 4 , Kaori Kobai 5 , Rikako Tanaka 4 , Mami Shibata 4 , Nozomu Shima 4 , Shigeki Nemoto 4 , Nobu Fukumoto 4 , Seiya Kato 4 Affiliations 1 Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. Electronic address: gomadofu@wakayama-med.ac.jp. 2 Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan. 3 Department of Infection Prevention and Control, Wakayama Medical University, Wakayama City, Wakayama, Japan; Department of Hematology/Oncology, Wakayama Medical University, Wakayama City, Wakayama, Japan. 4 Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama City, Wakayama, Japan. 5 Department of Anesthesiology, Wakayama Medical University, Wakayama City, Wakayama, Japan. Item in Clipboard CiteDisplay options Display options Format Abstract Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19. Keywords: COVID-19; Multisystem inflammatory syndrome; SARS-CoV-2. Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
3月 31, 2021 バイオアソシエイツ

宿主遺伝子の発現を阻害するウイルスタンパク質(Nsp1)を標的としたCOVID-19治療アプローチの可能性

Nsp1と呼ばれるコロナウイルスタンパク質が遺伝子の活性をどのように抑制し、ウイルス複製を促進するかを特定する研究は、新しい COVID-19 治療への希望をもたらすものだ。 パンデミックが始まって以来、科学者らは、 COVID-19 の原因となるコロナウイルスであるSARS-CoV-2を理解するために果てしなく取り組んできた。ワクチンの登場にもかかわらず、ウイルスはまだ蔓延しており、代替療法を開発する必要がある。…

ゲスト 1057人 と メンバー 6人 がオンラインです